NASDAQ:ARVN

Arvinas News Headlines

$61.34
+0.89 (+1.47 %)
(As of 04/13/2021 12:00 AM ET)
Add
Compare
Today's Range
$58.99
Now: $61.34
$62.08
50-Day Range
$58.19
MA: $69.56
$79.16
52-Week Range
$19.68
Now: $61.34
$92.77
Volume358,376 shs
Average Volume492,824 shs
Market Capitalization$3.00 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.14

Headlines

Arvinas (NASDAQ ARVN) News Headlines Today

SourceHeadline
BMO Capital Markets Initiates Coverage on Arvinas (NASDAQ:ARVN)BMO Capital Markets Initiates Coverage on Arvinas (NASDAQ:ARVN)
marketbeat.com - March 31 at 7:16 AM
Arvinas, Inc. (NASDAQ:ARVN) Expected to Post Earnings of -$0.77 Per ShareArvinas, Inc. (NASDAQ:ARVN) Expected to Post Earnings of -$0.77 Per Share
americanbankingnews.com - April 13 at 4:42 PM
Is ARVN Stock A Buy or Sell? - Yahoo FinanceIs ARVN Stock A Buy or Sell? - Yahoo Finance
finance.yahoo.com - April 12 at 7:26 PM
Is ARVN Stock A Buy or Sell?Is ARVN Stock A Buy or Sell?
finance.yahoo.com - April 12 at 7:26 PM
Ian Taylor Sells 25,000 Shares of Arvinas, Inc. (NASDAQ:ARVN) StockIan Taylor Sells 25,000 Shares of Arvinas, Inc. (NASDAQ:ARVN) Stock
americanbankingnews.com - April 7 at 8:04 PM
Arvinas Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021 - Yahoo FinanceArvinas Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021 - Yahoo Finance
finance.yahoo.com - April 5 at 10:50 PM
Arvinas Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021 - GlobeNewswireArvinas Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021 - GlobeNewswire
globenewswire.com - April 5 at 5:49 PM
Arvinas (NASDAQ:ARVN) Now Covered by BMO Capital MarketsArvinas (NASDAQ:ARVN) Now Covered by BMO Capital Markets
americanbankingnews.com - March 31 at 8:04 AM
Arvinas (NASDAQ:ARVN) Receives New Coverage from Analysts at BMO Capital MarketsArvinas (NASDAQ:ARVN) Receives New Coverage from Analysts at BMO Capital Markets
americanbankingnews.com - March 31 at 8:04 AM
Data-rich 2H21 could send Arvinas shares 140% higher, Cantor says - Seeking Alpha'Data-rich 2H21' could send Arvinas shares 140% higher, Cantor says - Seeking Alpha
seekingalpha.com - March 30 at 1:31 PM
Cantor Fitzgerald Increases Arvinas (NASDAQ:ARVN) Price Target to $140.00Cantor Fitzgerald Increases Arvinas (NASDAQ:ARVN) Price Target to $140.00
americanbankingnews.com - March 30 at 8:04 AM
Top Stocks To Short Today Amid More Hedge Fund Problems - ForbesTop Stocks To Short Today Amid More Hedge Fund Problems - Forbes
forbes.com - March 29 at 2:37 PM
Zacks: Brokerages Expect Arvinas, Inc. (NASDAQ:ARVN) Will Post Quarterly Sales of $4.00 MillionZacks: Brokerages Expect Arvinas, Inc. (NASDAQ:ARVN) Will Post Quarterly Sales of $4.00 Million
americanbankingnews.com - March 29 at 11:17 AM
Best Short Plays Today As Stocks Slip On Anniversary Of Bull Market - ForbesBest Short Plays Today As Stocks Slip On Anniversary Of Bull Market - Forbes
forbes.com - March 23 at 8:44 PM
Arvinas Enters Oversold Territory (ARVN) - NasdaqArvinas Enters Oversold Territory (ARVN) - Nasdaq
nasdaq.com - March 23 at 8:44 PM
Arvinas, Inc. (NASDAQ:ARVN) Receives Consensus Rating of "Buy" from AnalystsArvinas, Inc. (NASDAQ:ARVN) Receives Consensus Rating of "Buy" from Analysts
americanbankingnews.com - March 23 at 2:46 AM
Arvinas to Participate in Upcoming Virtual Investor Conferences - Yahoo FinanceArvinas to Participate in Upcoming Virtual Investor Conferences - Yahoo Finance
finance.yahoo.com - March 11 at 2:00 AM
Should You Buy AMERISAFE, Inc. (NASDAQ:AMSF) For Its Upcoming Dividend? - NasdaqShould You Buy AMERISAFE, Inc. (NASDAQ:AMSF) For Its Upcoming Dividend? - Nasdaq
nasdaq.com - March 6 at 10:38 PM
Analysts Have Just Cut Their Arvinas, Inc. (NASDAQ:ARVN) Revenue Estimates By 30%Analysts Have Just Cut Their Arvinas, Inc. (NASDAQ:ARVN) Revenue Estimates By 30%
nasdaq.com - March 6 at 12:36 PM
Arvinas Inc (ARVN) President and CEO John G Houston Sold $628,507 of SharesArvinas Inc (ARVN) President and CEO John G Houston Sold $628,507 of Shares
ca.finance.yahoo.com - March 4 at 10:13 AM
Today’s Top Shorts As Tech Stocks Lag With More Rising Bonds - ForbesToday’s Top Shorts As Tech Stocks Lag With More Rising Bonds - Forbes
forbes.com - March 3 at 7:11 PM
Arvinas Inc (ARVN) President and CEO John G Houston Sold $628,507 of Shares - Yahoo FinanceArvinas Inc (ARVN) President and CEO John G Houston Sold $628,507 of Shares - Yahoo Finance
finance.yahoo.com - March 3 at 12:40 AM
Arvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue Estimates - Yahoo FinanceArvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
finance.yahoo.com - March 2 at 7:39 PM
Arvinas: Q4 Earnings Insights - Yahoo FinanceArvinas: Q4 Earnings Insights - Yahoo Finance
finance.yahoo.com - March 2 at 7:39 PM
Arvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue Estimates - NasdaqArvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue Estimates - Nasdaq
nasdaq.com - March 1 at 6:29 PM
Arvinas Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update - Yahoo FinanceArvinas Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update - Yahoo Finance
finance.yahoo.com - March 1 at 6:29 PM
Arvinas: Q4 Earnings InsightsArvinas: Q4 Earnings Insights
finance.yahoo.com - March 1 at 1:28 PM
Arvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue EstimatesArvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue Estimates
finance.yahoo.com - March 1 at 1:28 PM
Arvinas: Q4 Earnings Insights - BenzingaArvinas: Q4 Earnings Insights - Benzinga
benzinga.com - March 1 at 8:28 AM
Arvinas Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update - GlobeNewswireArvinas Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update - GlobeNewswire
globenewswire.com - March 1 at 8:28 AM
Arvinas Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate UpdateArvinas Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - March 1 at 8:27 AM
Arvinas Inc (ARVN) CFO Sean A Cassidy Sold $3.3 million of Shares - Yahoo FinanceArvinas Inc (ARVN) CFO Sean A Cassidy Sold $3.3 million of Shares - Yahoo Finance
finance.yahoo.com - February 19 at 9:10 AM
What Kind Of Shareholders Hold The Majority In Arvinas, Inc.s (NASDAQ:ARVN) Shares? - Yahoo FinanceWhat Kind Of Shareholders Hold The Majority In Arvinas, Inc.'s (NASDAQ:ARVN) Shares? - Yahoo Finance
finance.yahoo.com - February 18 at 8:22 AM
What Kind Of Shareholders Hold The Majority In Arvinas, Inc.s (NASDAQ:ARVN) Shares?What Kind Of Shareholders Hold The Majority In Arvinas, Inc.'s (NASDAQ:ARVN) Shares?
finance.yahoo.com - February 18 at 8:22 AM
Arvinas, Inc. (ARVN) Upgraded to Buy: Heres Why - NasdaqArvinas, Inc. (ARVN) Upgraded to Buy: Here's Why - Nasdaq
nasdaq.com - February 17 at 2:29 PM
Connecticut Launches Marketing Initiative to Showcase Its Vibrant Life Sciences Ecosystem - Yahoo FinanceConnecticut Launches Marketing Initiative to Showcase Its Vibrant Life Sciences Ecosystem - Yahoo Finance
finance.yahoo.com - February 12 at 6:54 PM
Connecticut Launches Marketing Initiative to Showcase Its Vibrant Life Sciences Ecosystem - BenzingaConnecticut Launches Marketing Initiative to Showcase Its Vibrant Life Sciences Ecosystem - Benzinga
benzinga.com - February 11 at 6:02 PM
Arvinas to Present at the Guggenheim Healthcare Talks: 2021 Oncology Day - Yahoo FinanceArvinas to Present at the Guggenheim Healthcare Talks: 2021 Oncology Day - Yahoo Finance
finance.yahoo.com - February 8 at 6:05 PM
Arvinas to Present at the Guggenheim Healthcare Talks: 2021 Oncology DayArvinas to Present at the Guggenheim Healthcare Talks: 2021 Oncology Day
finance.yahoo.com - February 8 at 6:05 PM
Insiders Bullish on Certain Holdings of DWAS - NasdaqInsiders Bullish on Certain Holdings of DWAS - Nasdaq
nasdaq.com - February 5 at 2:33 PM
The Daily Biotech Pulse: FDA Greenlights Mercks Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - BenzingaThe Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Benzinga
benzinga.com - January 20 at 11:23 PM
The Daily Biotech Pulse: DBVs Positive FDA Feedback, Pfizers Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges - BenzingaThe Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges - Benzinga
benzinga.com - January 15 at 8:44 AM
Whats Next For Arvinas After A Solid 2x Increase? - NasdaqWhat's Next For Arvinas After A Solid 2x Increase? - Nasdaq
nasdaq.com - January 15 at 3:17 AM
Durham biotech CEO preps to challenge $60B market for crop protection - Triangle Business JournalDurham biotech CEO preps to challenge $60B market for crop protection - Triangle Business Journal
bizjournals.com - January 14 at 6:15 PM
Arvinas Inc. (ARVN) PT Raised to $121 at Cantor Fitzgerald - StreetInsider.comArvinas Inc. (ARVN) PT Raised to $121 at Cantor Fitzgerald - StreetInsider.com
streetinsider.com - January 5 at 7:20 AM
Arvinas: Leading In Cutting Edge Protein Degrader Development - Seeking AlphaArvinas: Leading In Cutting Edge Protein Degrader Development - Seeking Alpha
seekingalpha.com - January 3 at 1:02 AM
Arvinas, Inc. Announces Exercise of Underwriters Option to Purchase Additional Shares - GlobeNewswireArvinas, Inc. Announces Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewswire
globenewswire.com - December 28 at 5:54 PM
Arvinas, Inc. Announces Exercise of Underwriters’ Option to Purchase Additional SharesArvinas, Inc. Announces Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - December 28 at 5:54 PM
Arvinas - BenzingaArvinas - Benzinga
benzinga.com - December 27 at 12:00 AM
3 “Strong Buy” Stocks Insiders Are Snapping Up - Nasdaq3 “Strong Buy” Stocks Insiders Are Snapping Up - Nasdaq
nasdaq.com - December 24 at 12:06 AM
Tuesday 12/22 Insider Buying Report: ARVN, GWRE - NasdaqTuesday 12/22 Insider Buying Report: ARVN, GWRE - Nasdaq
nasdaq.com - December 22 at 12:12 PM
This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.